Huoxiang Zhengqi alleviates azoxymethane/dextran sulfate sodium-induced colitis-associated cancer by regulating Nrf2/NF-κB/NLRP3 signaling

• المؤلفون الرئيسيون: Mingyuan Dong (مؤلف), Honghan Liu (مؤلف), Tianjiao Cao (مؤلف), Lanzhou Li (مؤلف), Zhen Sun (مؤلف), Ye Qiu (مؤلف), Di Wang (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2022-10-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Colitis-associated cancer (CAC) is a subtype of inflammatory bowel disease (IBD)-associated colorectal cancer. Huoxiang Zhengqi (HXZQ) is a classical Chinese herbal medicine and has been used to treat intestinal disorders, however, anti-CAC effects and underlying mechanisms of HXZQ have not been rep...